Storage and handling
Other information Do not store above 30 o C or 86 o F
No7 Protect and Perfect Hand Sunscreen SPF 15
- Manufacturer
- BCM Ltd | The Boots Company PLC
- Effective date
- 2010-12-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:26:28
Label at a glance#
ProductNo7 Protect and Perfect Hand Sunscreen SPF 15
Active ingredientOCTINOXATE, AVOBENZONE, OCTISALATE
Label structure16 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com
www.boots.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
NO7 PROTECT AND PERFECT HAND CREAM SUNSCREEN SPF 15
Active ingredients Purpose
Octinoxate (7.5%) Sunscreens
Avobenzone (3.0%)
Octisalate (2.0%)
OTC - PURPOSE SECTION
Uses
- Provides moderate protection against the adverse effects of the sun
- Higher SPF gives more protection
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
When using this product
- Keep out of eyes. If contact occurs rinse thoroughly with cold water. Avoid direct contact with fabric.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash or irritation develops and lasts.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep our of reach of children. If swallowed, get medical help.
INDICATIONS & USAGE SECTION
Directions
- After cleansing, applying Protect and Perfect Hand Cream, simply smooth into your hands, avoiding contact your eyes.
- Apply evenly at least 15 minutes before sun exposure
- Reapply as required
- Not intended for children under the age of 12
- Not intended for protection while sunbathing
STORAGE AND HANDLING SECTION
Other information
Do not store above 30oC or 86oF
INACTIVE INGREDIENT SECTION
Inactive ingredients
Aqua (Water), C12-15 alkyl benzoate, Glycerin, Butyrospermum parkii (Shea butter), C18-36 acid glycol ester, Glyceryl stearate, Cetyl alcohol, PEG-100 stearate, Cyclopentasiloxane, Polyacrylamide, Cyclohexasiloxane, Phenoxyethanol, Tocopheryl acetate, C13-14 isoparaffin, Butylene glycol, Panthenol, Methylparaben, Parfum (Fragrance), Dimethiconol, Ethylparaben, Laureth-7, Acrylates/vinyl isodecanoate crosspolymer, Phytantriol, Undecylenoyl phenylalanine, Dipropylene glycol, Potassium sorbate, Tetrasodium EDTA, Potassium hydroxide, Lupinus albus seed extract, Carbomer, Agarum cribosum, Polysorbate 20, BHT, Butylparaben, Palmitoyl oligopeptide, Propylparaben, Isobutylparaben, Palmitoyl tetrapeptide-7
OTC - QUESTIONS SECTION
USA/Canada: Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
Appear Younger Longer...
This quickly and easily absorbed moisturiser vanishes to reveal beautifully younger looking hands with fine lines appearing reduced in just 2 weeks. Contains our patented whitening complex to help fade age spots and lipo-peptides to help boost and maintain elasticity. Hands remain conditioned even after washing. Formulated with Pro-Vitamin B5 to help strengthen nails and moisturise cuticles. SPF 15 helps protect against the ageing effects of the sun.
A little manicure every day ...
Smooth into hands every morning and any time they need a little extra care.
Dermatologically tested
This quickly and easily absorbed moisturiser vanishes to reveal beautifully younger looking hands with fine lines appearing reduced in just 2 weeks. Contains our patented whitening complex to help fade age spots and lipo-peptides to help boost and maintain elasticity. Hands remain conditioned even after washing. Formulated with Pro-Vitamin B5 to help strengthen nails and moisturise cuticles. SPF 15 helps protect against the ageing effects of the sun.
A little manicure every day ...
Smooth into hands every morning and any time they need a little extra care.
Dermatologically tested
INFORMATION FOR PATIENTS SECTION
Mfd in the UK/Fabriqué au R.-U
The Boots Company PLC Nottingham England NG2 3AA
Dist in the US by/aux É.-U par
Boots Retail USA Inc. Stamford CT06901
USA/Canada: Questions? 1-866-75-Boots
DESCRIPTION SECTION
Tube label
This quickly and easily absorbed moisturiser vanishes to reveal beautifully younger looking hands with fine lines appearing reduced in just 2 weeks. Contains our patented whitening complex to help fade age spots and lipo-peptides to help boost and maintain elasticity. Hands remain conditioned even after washing. Formulated with Pro-Vitamin B5 to help strengthen nails and moisturise cuticles. SPF 15 helps protect against the ageing effects of the sun.
A little manicure every day...
Smooth into hands every morning and any time they need a little extra care.
Avoid contact with eyes. If contact occurs rinse thoroughly with cold water.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients:
Octinoxate (7.5%), Avobenzone (3.0%), Octisalate (2.0%)
INFORMATION FOR PATIENTS SECTION
Mdf in the UK for/Fabriqué au R.-U.
The Boots Company PLC Nottingham England NG2 3AA
Dist in the USA by/aux É.U. par Boots Retail USA Inc. Stamford CT06901
USA/Canada: Questions? 1-866-75-BOOTSwww.boots.comPACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Carton label
No7 Protect and Perfect
Protection et Perfection
Hand Cream/Crème pour les mains
Conditions and protects for younger looking hands
Sunscreen SPF 15Hypo-allergenic
Boots
75ml e 2.5 US Fl. Oz
P and P Hand Cream carton.jpg
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Tube label
No7
Protect and Perfect
Protection et Perfection
Hand Cream
Crème pour les mains
Conditions and protects for younger looking hands
Sunscreen SPF 15
Hypo-allergenic
Boots
75ml e 2.5 US Fl. Oz
P and P Hand Cream tube.jpg
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11489-068-01 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c0e3-8e05-e053-dbdaa90a074a | Carton and tube labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11489-068-01 | No7 Protect and Perfect Hand Sunscreen SPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 11489-068-01 | No7 Protect and Perfect Hand Sunscreen SPF 15 | 75 mL in 1 TUBE | CREAM | 75 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE, DL- | INACTIVE INGREDIENT | WR1WPI7EW8 | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CARBOMER HOMOPOLYMER TYPE C | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Protect and Perfect Hand Sunscreen SPF 15
- Octinoxate, Avobenzone and Octisalate
- OCTINOXATE
- AVOBENZONE
- OCTISALATE
- WATER
- GLYCERIN
- SHEA BUTTER
- GLYCERYL MONOSTEARATE
- CETYL ALCOHOL
- CYCLOMETHICONE 5
- DIMETHICONE
- CYCLOMETHICONE 6
- PHENOXYETHANOL
- .ALPHA.-TOCOPHEROL ACETATE, DL-
- BUTYLENE GLYCOL
- PANTHENOL
- METHYLPARABEN
- ETHYLPARABEN
- POTASSIUM SORBATE
- POTASSIUM HYDROXIDE
- CARBOMER HOMOPOLYMER TYPE C
- POLYSORBATE 20
- BUTYLATED HYDROXYTOLUENE
- BUTYLPARABEN
- PROPYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11489-068 | 11489-068-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| CARBOMER HOMOPOLYMER TYPE C | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | OINTMENT, AUGMENTED / TOPICAL | 23 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE / ORAL | 172 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE, DL- | .ALPHA.-TOCOPHEROL ACETATE, DL- | WR1WPI7EW8 | OINTMENT / TOPICAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | 1 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE / ORAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRA-ARTICULAR | 0.03 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RECTAL | 0.02 %w/v | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAMUSCULAR | 95 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / TOPICAL | 3 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, EXTENDED RELEASE / ORAL | 132 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / NASAL | 250 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CONCENTRATE / ORAL | 12 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SYRUP / ORAL | 40 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | DROPS / ORAL | NA | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | 45 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c3d2f3c2-c762-4d6d-9f32-5e6273666193 | d1a360d0-7308-4349-84d8-b8e06f69f5a2 | 2010-12-02 | Warnings | c3d2f3c2-c762-4d6d-9f32-5e6273666193 d1a360d0-7308-4349-84d8-b8e06f69f5a2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.